La Nevera Rojo, PizzaBo and HelloFood subsidiaries in Italy, Brazil and Mexico have been acquired by JustEat, as Rocket looks to shift excess operations.

The China-based immuno-oncology company, backed by Merck & Co since 2011, floated at the top of it range and has gained since its debut yesterday.

Genome editing company Editas, backed by Alphabet and Partners Healthcare, has secured $94.4m, pricing the initial public offering at the bottom of the $16 to $18 range.

The company could secure up to $60.8m in proceeds, having previously raised equity and debt from investors such as Novartis, Sanofi and Elan Science One.

The educational data analytics platform developer had raised almost $5m across two early-stage rounds from investors including Samsung Ventures.

Roche-backed AveXis, the developer of a spinal muscular atrophy treatment, intends to issue 4.25 million shares priced between $19 and $21.

Juniper Networks is set to acquire networking software company BTI Systems, which had raised $60m in equity from backers including Fujitsu, for an undisclosed sum.

Alibaba will sell a stake in China Internet Plus, formed by the merger of Dianping and Meituan late last year, said to be sized at about 7%.

Immunotherapy developer Adicet Bio revealed the series A funding alongside its acquisition of Israel-based Applied Immune Technologies.